|
ODP Prevention Scientific Interest Groups (SIGs)
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, OASH, FDA
|
OD/DPCPSI/ODP, NCCIH, NCI, NHGRI, NHLBI, NIA, NIAAA, NIAMS, NICHD, NIDA, NIDCR, NIDDK, NIMHD, NINDS
|
The Office of Disease Prevention (ODP) Prevention Scientific Interest Groups (SIGs) develop collaborative research initiatives to address unmet prevention research needs. To avoid overlap with other collaborative research planning groups, they focus on areas where there are no existing collaborative NIH-wide or federal groups.
|
|
Office for Human Research Protections/Division of Human Subjects Research
|
Meeting/ Workshop
|
OS
|
OD/OER
|
The Office for Human Research Protections (OHRP) collaborated with the NIH OER Division of Human Subjects Research to provide comprehensive human subjects protection training at the NIH Virtual Meeting PreCon event for the extramural community.
|
|
Office of AIDS Research Advisory Council (OARAC)
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
OD/DPCPSI/OAR, OD, NIAID, OD/DPCPSI
|
The Office of AIDS Research Advisory Council (OARAC) provides advice to the Office of AIDS Research (OAR) Director on the planning, coordination, and evaluation of research and other HIV/AIDS activities conducted or supported by the National Institutes of Health (NIH). The OARAC advises the Secretary of Health and Human Services, the Assistant Secretary for Health, the Director of NIH, and the Director of OAR on HIV/AIDS research programs and the development and annual review of the comprehensive NIH Strategic Plan for HIV and HIV-Related Research.
|
|
Office of Emergency Care (OECR)-FDA Update Meetings
|
Meeting/ Workshop
|
FDA
|
NINDS
|
The NINDS Office for Emergency Care Research (OECR) and the FDA meet quarterly to learn of each other's ongoing activities and streamline any areas of overlap.
|
|
Office of National Drug Control Policy (ONDCP) Data Interagency Working Group (DIWG)
|
Committee, Work group, Advisory group, or Task Force
|
ACF, ACL, AHRQ, ASA, ASPE, CDC, CMS, FDA, IHS, NIH, ONC, SAMHSA
|
NIDA, NIAAA
|
The Office of National Drug Control Policy (ONDCP) Data Interagency Working Group (DIWG) is led by ONDCP to review and recommend drug data and research to address the policy priorities articulated by the current Administration. Agency contributions will help inform and be incorporated into the National Drug Control Strategy.
|
|
Office of Secretary, Patient-Centered Outcomes Research Trust Fund (OS-PCORTF) PCORTF Projects titled, Data Capacity for PCOR through eCare Planning for People with Multiple Chronic Conditions Disability.
|
Other
|
ACL, AHRQ, IHS
|
NHLBI, NCI, NIA, NIDDK, NLM
|
This project aims to improve the accessibility of patient-centered data for research and care by developing an accessible, interoperable, person-centered electronic (e)care plan.
|
|
Office of the Clinical Director Clinical Services Research
|
Research Initiative
|
IHS
|
NIMH
|
Office of the Clinical Director Clinical Services Research
|
|
Older Individuals Collaborative Nutrition Group (OICN)
|
Meeting/ Workshop
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, NIH, OASH, OS, ACL
|
OD/DPCPSI/ODP, NIA, OD/DPCPSI/ODSS, OD/DPCPSI/ODS, OD/DPCPSI/ONR
|
The purpose of this group is to connect and inform federal nutrition and public health researchers, educators, communicators, and policy makers across federal agencies who touch the lives of older adults.
|
|
ONDCP Harm Reduction Interagency Workgroup
|
Committee, Work group, Advisory group, or Task Force
|
SAMHSA, ASPE, CMS, HRSA, CDC
|
NIDA
|
This interagency working group (IWG) will help drive action in support of the Biden-Harris Administration goal of increasing access to evidence-based harm reduction services through expanded Medicaid reimbursement, comprehensive federal grant funding, research, and workforce training. Specifically, the IWG will focus on integrating harm reduction services with traditional health care infrastructure by developing sustainable funding streams needed to expand the availability of syringe services programs, naloxone, fentanyl test strips, and low-threshold medication treatment for opioid use disorder at harm reduction programs, as outlined in the 2022 National Drug Control Strategy.
|
|
ONDCP Methadone Modernization Interagency Workgroup
|
Committee, Work group, Advisory group, or Task Force
|
SAMHSA, HRSA, CMS
|
NIDA
|
This interagency workgroup (IWG) will help drive action in support of the Biden-Harris Administration goal of reducing barriers and increasing access to evidence-based treatment, specifically methadone for opioid use disorder (OUD). In line with the goals set forth in the 2022 National Drug Control Strategy, this IWG will work to review and update regulations governing opioid treatment programs (OTP) - currently the only location where patients can access methadone - to make it easier for patients to initiate and stay in treatment. This work to remove barriers to methadone access will also support the Strategy goal of increasing the availability of methadone in jails and prisons.
|